481 filings
Page 18 of 25
8-K
cq328ys2up3yh8koba86
9 Mar 20
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
8:00am
SC 13D/A
xeeu7g2ywur9diraw19
6 Mar 20
BioXcel Therapeutics, Inc.
11:13am
SC 13D/A
dxuzgt0jdhu
24 Feb 20
BioXcel Therapeutics, Inc.
9:30am
424B5
4m8pjhh6z euqyzp6m
20 Feb 20
Prospectus supplement for primary offering
9:54pm
8-K
mdow65vkmpagi3xgmwyq
20 Feb 20
Entry into a Material Definitive Agreement
9:50pm
4
zutsblmihbiqe
19 Feb 20
BioXcel Therapeutics / Frank Yocca ownership change
5:22pm
8-K
dp2ld2hw22dpad
19 Feb 20
Results of Operations and Financial Condition
5:11pm
424B5
nfpl p44m0u1y
19 Feb 20
Prospectus supplement for primary offering
5:07pm
SC 13D/A
qspri9krrqg1
18 Feb 20
Beneficial ownership report (amended)
10:18am
4
n5gcr0eq31
14 Feb 20
BioXcel Therapeutics / PETER MUELLER ownership change
12:00am
3/A
5b6ukhr mof3rhs
14 Feb 20
BioXcel Therapeutics / PETER MUELLER ownership change
12:00am
SC 13G/A
8djm24v202jp
7 Feb 20
Beneficial ownership report (amended)
12:00am
8-K
33ilg6wb3li8r
13 Jan 20
Regulation FD Disclosure
9:12am
S-8
x0i6tpv
26 Nov 19
Registration of securities for employees
5:06pm
8-K
56y y99pia
14 Nov 19
BioXcel Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
8:00am
424B5
an1ed7earywimt rstlp
28 Sep 19
Prospectus supplement for primary offering
1:42am
8-K
wk7ibf08gwv
27 Sep 19
Other Events
5:31pm